Literature DB >> 7600743

Does abnormal QT interval prolongation reflect autonomic dysfunction in diabetic patients? QTc interval measure versus standardized tests in diabetic autonomic neuropathy.

M Veglio1, A Chinaglia, M Borra, P C Perin.   

Abstract

The question as to whether the QTc interval correlates with five cardiovascular tests (deep breathing test, 30/15 ratio test, lying to standing test, cough test, and postural blood pressure test) for the diagnosis of diabetic autonomic neuropathy (DAN) was investigated in 168 (38 Type 1, 130 Type 2) consecutive outpatients (mean age 54.9 +/- 11.2 years). QT interval was measured on an ECG recorded at rest and QTc calculated according to Bazett's formula. The percentage of patients with a QTc greater than 0.440 s was: absent DAN = 11% (n = 7), probable DAN = 7% (n = 4), definite DAN = 23% (n = 12) (p < 0.05), and the mean (+/- SD) QTc values were 0.403 +/- 0.028 s, 0.405 +/- 0.023 s, and 0.421 +/- 0.026 s, respectively. A significant correlation between QTc duration and DAN score of autonomic cardiovascular test results (r = 0.34, p < 0.0001) was observed. The calculated specificity, sensitivity, positive and negative predictive values were 89%, 15%, 70% and 37%, respectively. In conclusion, QTc can be considered as an additional specific test in the assessment of diabetic autonomic neuropathy, but cannot replace the standard battery of cardiovascular tests.

Entities:  

Mesh:

Year:  1995        PMID: 7600743     DOI: 10.1111/j.1464-5491.1995.tb00481.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  9 in total

Review 1.  Epidemiology of sudden cardiac death: clinical and research implications.

Authors:  Sumeet S Chugh; Kyndaron Reinier; Carmen Teodorescu; Audrey Evanado; Elizabeth Kehr; Mershed Al Samara; Ronald Mariani; Karen Gunson; Jonathan Jui
Journal:  Prog Cardiovasc Dis       Date:  2008 Nov-Dec       Impact factor: 8.194

2.  QTc interval, and autonomic and somatic nerve function in diabetic neuropathy.

Authors:  H Katsuoka; Y Mimori; K Kurokawa; T Harada; T Kohriyama; F Ishizaki; A Harada; S Nakamura
Journal:  Clin Auton Res       Date:  1998-06       Impact factor: 4.435

3.  QT interval and QT dispersion in multiple system atrophy (Shy-Drager syndrome).

Authors:  D Frongillo; F Stocchi; F A Delfino; L Calò; L Bramante; F Antonucci; D De Nardo; S Ruggleri; D Cannata
Journal:  Clin Auton Res       Date:  1996-04       Impact factor: 4.435

4.  Can abnormalities of ventricular repolarisation identify insulin dependent diabetic patients at risk of sudden cardiac death?

Authors:  P J Weston; J M Glancy; P G McNally; H Thurston; D P de Bono
Journal:  Heart       Date:  1997-07       Impact factor: 5.994

5.  Use of corrected QT interval in autonomic function testing: assessment of reproducibility.

Authors:  M Veglio; S Maule; C Matteoda; R Quadri; M Valentini; O Pecchio; G Piancino; L Chiandussi
Journal:  Clin Auton Res       Date:  1996-12       Impact factor: 4.435

6.  QTc interval and resting heart rate as long-term predictors of mortality in type 1 and type 2 diabetes mellitus: a 23-year follow-up.

Authors:  C Stettler; A Bearth; S Allemann; M Zwahlen; L Zanchin; M Deplazes; E R Christ; A Teuscher; P Diem
Journal:  Diabetologia       Date:  2006-11-10       Impact factor: 10.122

7.  QT & RR variability spots the earliest autonomic deregulation in diabetes. Fading of vagal sino-atrial drive but not of sympathetic ventricular responsiveness to life challenges.

Authors:  Radu Negoes; Oana Istrătescu; Mihaela Dincă-Panaitescu; Erban Dincă-Panaitescu; Alin Achim
Journal:  Integr Physiol Behav Sci       Date:  2002 Apr-Jun

8.  Assessing the impact of a combination of sofosbuvir and daclatasvir treatment for hepatitis C virus infection on heart rate, rhythm and heart rate variability using 24-hour ECG monitoring.

Authors:  Ahmed Mohamed El Missiri; Mona Mostafa Rayan; Mohamed Medhat Awad; Ahmed Ibrahim El Desoky
Journal:  Egypt Heart J       Date:  2020-07-01

9.  QTc prolongation in Black diabetic subjects with cardiac autonomic neuropathy.

Authors:  Ogba J Ukpabi; Basden Jc Onwubere
Journal:  Afr Health Sci       Date:  2017-12       Impact factor: 0.927

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.